Clean ClAImsFirst Pass

Humata Health vs Infinx

Two Prior Authorization vendors, side by side. Facts from public sources; judgments are ours.

At a glance

Derived from public facts · a rough scale, not a ranking

Humata HealthInfinx
Pricing model

Enterprise contract (custom) · Priced on volume and workflow complexity

Enterprise contract (custom) · Software plus services, quote-based

Speed to go live

EHR-embedded, standard integration project

Standard EHR integration project

Automation model

Autonomous agents · Touchless prior auth, exception-based review

Tech-enabled service · AI agents plus expert staff

Built for

Mid-size groups, Enterprise systems, Payers

Mid-size groups, Enterprise systems, Billing companies

Security posture

SOC 2 Type II, HITRUST, HIPAA

HITRUST, SOC 2 Type II, HIPAA

Company maturity

3 yrs (est. 2023)

14 yrs (est. 2012)

Financial backing

$25M+ · Series A

$186M reported · Growth (KKR minority stake 2024)

Named customers

5 named

None public

Published results

No public numbers

No public numbers

Documented integrations

4 listed

5 listed

Third-party validation

None found

None found

Bottom line

  • Pick Humata Health if prior auth volume is drowning your staff and you want touchless submissions inside the EHR with payer-grade compliance credentials.
  • Pick Infinx if you want prior auth and revenue cycle work handled by a blend of AI and human specialists rather than buying software your staff must run.

Humata Health

AI prior authorization for providers and payers

Founded
2023
HQ
Orlando, FL
Stage
Series A
Raised
$25M+

What it does

  • Matches payer policies to determine if prior auth is required
  • Auto-gathers and bundles clinical documentation for submission
  • Submits authorizations touchlessly across payer connections
  • Monitors auth status and flags changes after submission
  • Detects CPT mismatches before submission
  • Supports gold-carding and exception-based review workflows

Where it's strong

  • Founder Jeremy Friese, MD previously built and sold Verata Health, so this is a second product in the same category, not a first attempt.
  • Strategic investors on the payer side (Blue Venture Fund, Optum Ventures, Highmark Ventures) give it unusual payer connectivity for a provider-facing tool.
  • Real deployment scale for its age: roughly 225 hospitals and 42,000 physicians, plus CMS selecting it as a technology partner for the WISeR model.

What buyers should weigh

  • Headline metrics like 96% first-pass approval and 45% fewer manual touches are vendor-reported, so validate them against your own service lines in a pilot.
  • Its role as an AI clinical-review partner in the CMS WISeR model puts it on both the provider and payer sides of prior auth, which some provider organizations may see as a conflict.
  • The company traces back to prior authorization assets from Olive AI, which shut down, so diligence which parts of the platform are new versus inherited.

Named customers

Texas Health Resources · Hartford HealthCare · Renown Health · Rochester Regional Health · Lee Health

Integrations

EpicOracle HealthMicrosoft Dragon CopilotPayer portals and clearinghouses
Full Humata Health profile →

Infinx

AI plus specialists for prior auth and patient access

Founded
2012
HQ
San Jose, CA
Stage
Growth (KKR minority stake 2024)
Raised
$186M reported

What it does

  • AI prior authorization determination, submission, and status tracking
  • Eligibility verification and benefits checks in one platform
  • Patient pay estimates before service
  • Certified specialists work exceptions automation cannot resolve
  • AR recovery and denial management services

Where it's strong

  • The AI-plus-human model delivers completed authorizations, not just software your staff still has to work.
  • Deep roots in high-volume prior auth specialties like radiology, labs, and cardiology.
  • Trusted by more than 900 provider organizations, with KKR and Norwest backing.

What buyers should weigh

  • Part of the value is outsourced labor, so compare its per-transaction economics against pure software options.
  • Named customer references are rare in public materials; case studies are anonymized.
  • Broad service catalog means implementation scope needs careful definition up front.

Integrations

EpicCernerathenahealtheClinicalWorksNextGen
Full Infinx profile →

Compare against the rest of Prior Authorization

Deciding between these two?

First Pass tracks Prior Authorization every week: funding, launches, and what changed since this page was written.